Synthesis and biological evaluation of novel anti-tumour (E)-styrylsulfonyl methylpyridines
ON01910.Na (Rigosertib, Estybon®), a styryl benzylsulfone, is a Phase III stage anti-cancer agent. This non-ATP competitive kinase inhibitor has multi-targeted activity, promoting mitotic arrest and apoptosis. Extensive Phase I/II studies with ON01910.Na, conducted in patients with solid tumours and...
Main Author: | Lu, Tiangong |
---|---|
Published: |
University of Nottingham
2014
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.639916 |
Similar Items
-
Molecular expression of recombinant Apoptin in planta and preliminary evaluation of biological characteristics of plant-made Apoptin on cancerous cells
by: Chan, Xiao Ying
Published: (2017) -
Structural modification of Clusianone from Garcinia parvifolia and in vitro evaluation targeting microtubule system of respiratory carcinoma
by: Nagalingam, Sree Vaneesa
Published: (2017) -
Cardamonin induces apoptosis in human nasopharyngeal carcinoma cells via mitochondrial death pathway mediated by caspase-3 and caspase-8 activation, independent of caspase-9 signalling responses
by: Chiang, Michelle
Published: (2016) -
Organogels for intratumoural delivery
by: Mohamed, Masar Basim Mohsin
Published: (2017) -
Computer-aided design and synthesis of novel anti-DENV nucleoside analogues
by: Cima, Cecilia
Published: (2017)